TipRanks
Genscript Biotech (GNNSF)
OTHER OTC:GNNSF
US Market
GNNSF
Genscript Biotech
RESEARCH TOOLSreports

Genscript Biotech (GNNSF) Income Statement

22 Followers

Genscript Biotech Income Statement

Last quarter (Q2 2026), Genscript Biotech's total revenue was $403.25M, an increase of 41.41% from the same quarter last year. In Q2, Genscript Biotech's net income was $-129.03M. See Genscript Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 959.53M$ 594.49M$ 560.48M$ 625.70M$ 490.10M
Gross Profit
$ 553.20M$ 272.13M$ 270.63M$ 304.08M$ 282.52M
Operating Expenses
$ 297.96M$ 262.84M$ 244.44M$ 742.06M$ 661.81M
Depreciation and Amortization
$ 62.36M$ 60.75M$ 57.30M$ 49.08M$ 37.72M
EBITDA
$ 317.61M$ 70.04M$ 83.50M$ -389.04M$ -477.27M
Operating Income
$ 255.25M$ 9.28M$ 26.19M$ -438.11M$ -379.29M
Other Income/Expenses
$ -725.78M$ -180.08M$ 142.69M$ 6.29M$ -138.07M
Pretax Income
$ -470.53M$ -170.80M$ 168.88M$ -431.69M$ -517.36M
Net Income
$ -532.83M$ 2.96B$ -95.48M$ -226.85M$ -358.71M
Per Share Metrics
Basic EPS
$ -0.25$ -0.03$ 0.20$ -0.11$ -0.18
Diluted EPS
$ -0.25$ -0.03$ 0.20$ -0.11$ -0.18
Weighted Average Shares Outstanding
 2.17B 2.18B 2.11B 2.10B 2.03B
Weighted Average Shares Outstanding (Diluted)
 2.19B 2.18B 2.11B 2.10B 2.03B
Currency in USD

Genscript Biotech Earnings and Revenue History